These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20840353)

  • 1. Gender-specific aspects in the clinical presentation of cardiovascular disease.
    Leuzzi C; Sangiorgi GM; Modena MG
    Fundam Clin Pharmacol; 2010 Dec; 24(6):711-7. PubMed ID: 20840353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender determinants of cardiovascular risk factors and diseases.
    Mercuro G; Deidda M; Piras A; Dessalvi CC; Maffei S; Rosano GM
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):207-20. PubMed ID: 19829128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease.
    Johnson SM; Karvonen CA; Phelps CL; Nader S; Sanborn BM
    J Womens Health (Larchmt); 2003 Jun; 12(5):449-57. PubMed ID: 12869292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific features of plasmatic and circulating cell alterations as risk factors in cardiovascular disease.
    Straface E; Lista P; Gambardella L; Franconi F; Malorni W
    Fundam Clin Pharmacol; 2010 Dec; 24(6):665-74. PubMed ID: 20636365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and epidemiology of hypertensive cardiovascular disease in women: the size of the problem.
    Franklin SS
    J Hypertens Suppl; 2002 May; 20(2):S3-5. PubMed ID: 12183848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease prevention in women: a rapidly evolving scenario.
    Stranges S; Guallar E
    Nutr Metab Cardiovasc Dis; 2012 Dec; 22(12):1013-8. PubMed ID: 23123148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why is cardiovascular health important in menopausal women?
    Simon T
    Climacteric; 2006 Sep; 9 Suppl 1():13-8. PubMed ID: 16899439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease prevention in women: Impact of dietary interventions.
    Hoekstra T; Beulens JW; van der Schouw YT
    Maturitas; 2009 May; 63(1):20-7. PubMed ID: 19307070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender disparities in the quality of cardiovascular disease care in private managed care plans.
    Chou AF; Scholle SH; Weisman CS; Bierman AS; Correa-de-Araujo R; Mosca L
    Womens Health Issues; 2007; 17(3):120-30. PubMed ID: 17448685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of sex-specific results reporting in cardiovascular disease.
    Blauwet LA; Redberg RF
    Cardiol Rev; 2007; 15(6):275-8. PubMed ID: 18090061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology.
    Stramba-Badiale M; Fox KM; Priori SG; Collins P; Daly C; Graham I; Jonsson B; Schenck-Gustafsson K; Tendera M
    Eur Heart J; 2006 Apr; 27(8):994-1005. PubMed ID: 16522654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women in Pakistan have a greater burden of clinical cardiovascular risk factors than men.
    Jafar TH
    Int J Cardiol; 2006 Jan; 106(3):348-54. PubMed ID: 16337043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.
    Ferrara A; Mangione CM; Kim C; Marrero DG; Curb D; Stevens M; Selby JV;
    Diabetes Care; 2008 Jan; 31(1):69-74. PubMed ID: 17934157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).
    Bannink L; Wells S; Broad J; Riddell T; Jackson R
    N Z Med J; 2006 Nov; 119(1245):U2313. PubMed ID: 17146488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension.
    Li C; Engström G; Hedblad B; Janzon L
    J Hypertens; 2006 Aug; 24(8):1523-9. PubMed ID: 16877954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.